avantor inc. - AVTR
AVTR
Close Chg Chg %
13.36 0.11 0.79%
Pre-Market
13.47
+0.11 (0.79%)
Volume: 11.20M
Last Updated:
May 20, 2025, 3:59 PM EDT
Company Overview: avantor inc. - AVTR
AVTR Key Data
| Open $13.40 | Day Range 13.32 - 13.64 |
| 52 Week Range 11.82 - 28.00 | Market Cap $9.10B |
| Shares Outstanding 681.43M | Public Float 663.12M |
| Beta 1.09 | Rev. Per Employee N/A |
| P/E Ratio 12.75 | EPS $1.05 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 15.42M |
AVTR Performance
| 1 Week | 0.45% | ||
| 1 Month | -10.79% | ||
| 3 Months | -22.14% | ||
| 1 Year | -44.20% | ||
| 5 Years | -24.45% |
AVTR Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
24
Full Ratings ➔
About avantor inc. - AVTR
Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. Its portfolio includes biopharma, healthcare, education and government, as well as advanced technologies and applied materials industries. It sells materials, equipment, instrumentation, and offers specialty procurement. The company operates through the following geographical segments: the Americas, Europe, and AMEA. Avantor was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.
AVTR At a Glance
Avantor, Inc.
One Radnor Corporate Center
Radnor, Pennsylvania 19087-4515
| Phone | 1-610-386-1700 | Revenue | 6.78B | |
| Industry | Medical Distributors | Net Income | 711.50M | |
| Sector | Distribution Services | Employees | 13,500 | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
AVTR Valuation
| P/E Current | 12.746 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 20.194 |
| Price to Sales Ratio | 2.118 |
| Price to Book Ratio | 2.408 |
| Price to Cash Flow Ratio | 17.088 |
| Enterprise Value to EBITDA | 16.144 |
| Enterprise Value to Sales | 2.703 |
| Total Debt to Enterprise Value | 0.231 |
AVTR Efficiency
| Revenue/Employee | 502,488.889 |
| Income Per Employee | 52,703.704 |
| Receivables Turnover | 6.557 |
| Total Asset Turnover | 0.541 |
AVTR Liquidity
| Current Ratio | 1.069 |
| Quick Ratio | 0.705 |
| Cash Ratio | 0.13 |
AVTR Profitability
| Gross Margin | 29.181 |
| Operating Margin | 10.764 |
| Pretax Margin | 12.588 |
| Net Margin | 10.489 |
| Return on Assets | 5.672 |
| Return on Equity | 12.695 |
| Return on Total Capital | 6.985 |
| Return on Invested Capital | 7.132 |
AVTR Capital Structure
| Total Debt to Total Equity | 70.992 |
| Total Debt to Total Capital | 41.518 |
| Total Debt to Total Assets | 34.907 |
| Long-Term Debt to Equity | 56.708 |
| Long-Term Debt to Total Capital | 33.164 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Avantor Inc. - AVTR
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 7.39B | 7.51B | 6.97B | 6.78B | |
Sales Growth
| +15.52% | +1.71% | -7.26% | -2.64% | |
Cost of Goods Sold (COGS) incl D&A
| 5.17B | 5.23B | 4.91B | 4.80B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 379.20M | 405.50M | 402.30M | 405.50M | |
Depreciation
| 88.40M | 87.20M | 94.60M | 105.70M | |
Amortization of Intangibles
| 290.80M | 318.30M | 307.70M | 299.80M | |
COGS Growth
| +11.98% | +1.04% | -6.06% | -2.18% | |
Gross Income
| 2.21B | 2.28B | 2.06B | 1.98B | |
Gross Income Growth
| +24.75% | +3.28% | -10.00% | -3.73% | |
Gross Profit Margin
| +29.95% | +30.41% | +29.51% | +29.18% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 1.14B | 1.13B | 1.16B | 1.25B | |
Research & Development
| - | - | - | - | - |
Other SG&A
| 1.14B | 1.13B | 1.16B | 1.25B | |
SGA Growth
| +8.18% | -0.80% | +2.46% | +7.75% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 98.40M | 25.50M | 194.50M | 90.20M | |
EBIT after Unusual Expense
| 972.80M | 1.13B | 702.20M | 640.00M | |
Non Operating Income/Expense
| (2.40M) | (2.70M) | 23.80M | 542.20M | |
Non-Operating Interest Income
| - | - | - | 75.10M | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 217.40M | 273.60M | 315.50M | 328.30M | |
Interest Expense Growth
| -29.32% | +25.85% | +15.31% | +4.06% | |
Gross Interest Expense
| 217.40M | 273.60M | 315.50M | 328.30M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 753.00M | 851.10M | 410.50M | 853.90M | |
Pretax Income Growth
| +1,108.67% | +13.03% | -51.77% | +108.01% | |
Pretax Margin
| +10.19% | +11.33% | +5.89% | +12.59% | |
Income Tax
| 180.40M | 164.60M | 89.40M | 142.40M | |
Income Tax - Current - Domestic
| 106.30M | 152.10M | 146.20M | 128.00M | |
Income Tax - Current - Foreign
| 91.80M | 81.60M | 115.60M | 61.30M | |
Income Tax - Deferred - Domestic
| 13.50M | (22.40M) | (19.80M) | (18.10M) | |
Income Tax - Deferred - Foreign
| (31.20M) | (46.70M) | (152.60M) | (28.80M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 572.60M | 686.50M | 321.10M | 711.50M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 572.60M | 686.50M | 321.10M | 711.50M | |
Net Income Growth
| +391.08% | +19.89% | -53.23% | +121.58% | |
Net Margin Growth
| +7.75% | +9.14% | +4.61% | +10.49% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 572.60M | 686.50M | 321.10M | 711.50M | |
Preferred Dividends
| - | - | 64.60M | 24.20M | - |
Net Income Available to Common
| 508.00M | 662.30M | 321.10M | 711.50M | |
EPS (Basic)
| 0.8603 | 1.0175 | 0.4753 | 1.0469 | |
EPS (Basic) Growth
| +853.77% | +18.27% | -53.29% | +120.26% | |
Basic Shares Outstanding
| 590.50M | 650.90M | 675.60M | 679.60M | |
EPS (Diluted)
| 0.8472 | 1.0104 | 0.4733 | 1.0434 | |
EPS (Diluted) Growth
| +850.84% | +19.26% | -53.16% | +120.45% | |
Diluted Shares Outstanding
| 599.60M | 679.40M | 678.40M | 681.90M | |
EBITDA
| 1.45B | 1.56B | 1.30B | 1.14B | |
EBITDA Growth
| +30.20% | +7.45% | -16.65% | -12.57% | |
EBITDA Margin
| +19.64% | +20.74% | +18.64% | +16.74% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 17.868 | |
| Number of Ratings | 24 | Current Quarters Estimate | 0.248 | |
| FY Report Date | 06 / 2025 | Current Year's Estimate | 1.028 | |
| Last Quarter’s Earnings | 0.23 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 0.99 | Next Fiscal Year Estimate | 1.141 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 21 | 21 | 22 | 22 |
| Mean Estimate | 0.25 | 0.26 | 1.03 | 1.14 |
| High Estimates | 0.27 | 0.29 | 1.07 | 1.23 |
| Low Estimate | 0.23 | 0.24 | 0.98 | 1.05 |
| Coefficient of Variance | 2.98 | 4.19 | 2.45 | 4.57 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 8 | 8 | 12 |
| OVERWEIGHT | 3 | 3 | 4 |
| HOLD | 12 | 12 | 8 |
| UNDERWEIGHT | 1 | 0 | 0 |
| SELL | 0 | 1 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Avantor Inc. - AVTR
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Avantor Inc. - AVTR
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Apr 9, 2025 | Christophe Couturier EVP, AMEA | 83,840 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $15.13 per share | 1,268,499.20 |
| Mar 3, 2025 | Steven W. Eck SVP & Chief Accounting Officer | 40,604 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $17.53 per share | 711,788.12 |
| Mar 3, 2025 | Steven W. Eck SVP & Chief Accounting Officer | 39,571 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $17 per share | 672,707.00 |
| Mar 3, 2025 | James Bramwell EVP Sales, Customer Excellence | 87,379 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $17.53 per share | 1,531,753.87 |
| Mar 3, 2025 | James Bramwell EVP Sales, Customer Excellence | 86,605 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $17 per share | 1,472,285.00 |
| Feb 27, 2025 | Michael Stubblefield President & CEO; Director | 1,452,991 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $17.47 per share | 25,383,752.77 |
| Feb 27, 2025 | Michael Stubblefield President & CEO; Director | 1,448,022 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $17.56 per share | 25,427,266.32 |
| Feb 27, 2025 | Christophe Couturier EVP, AMEA | 84,409 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $17.56 per share | 1,482,222.04 |
| Feb 27, 2025 | Brittany Hankamer EVP, Chief HR Officer | 49,964 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $17.47 per share | 872,871.08 |
| Feb 27, 2025 | Brittany Hankamer EVP, Chief HR Officer | 49,595 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $17.56 per share | 870,888.20 |
| Jul 23, 2024 | Kitty Sahin EVP, Strategy&Corp Development | 42,274 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $20.74 per share | 876,762.76 |
| Jun 26, 2024 | Corey Walker President Laboratory Solutions | 28,254 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 26, 2024 | Corey Walker President Laboratory Solutions | 70,462 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |